Home   Business   Life Science

Subscribe Now

Life Science




Horizon Discovery snapped up by US-based PerkinElmer for $383m

Horizon Discovery snapped up by US-based PerkinElmer for $383m

Horizon Discovery snapped up by US-based PerkinElmer for $383m

The board of the Waterbeach-based cell engineering specialist say the company is ready for a US listing.


AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

AstraZeneca’s open courtyard takes shape on Cambridge Biomedical Campus as trees planted

When the R&D Centre opens, the courtyard will be open to the public.


Kao Data discusses the growth of high performance computing in the life sciences

Kao Data discusses the growth of high performance computing in the life sciences

Kao Data discusses the growth of high performance computing in the life sciences

Director Adam Nethersole discusses how the pandemic has highlighted the importance of HPC for the sector.


bit.bio + London Institute for Mathematical Sciences = progress on industrial-scale production of all human cells

bit.bio + London Institute for Mathematical Sciences=progress on industrial-scale production of all human cells

bit.bio + London Institute for Mathematical Sciences = progress on industrial-scale production of all human cells

The new partnership will enable new cell therapies and even accelerate prototype organ printing.


AstraZeneca presents new data on renal portfolio at ASN Kidney Week 2020 Reimagined

AstraZeneca presents new data on renal portfolio at ASN Kidney Week 2020 Reimagined

AstraZeneca presents new data on renal portfolio at ASN Kidney Week 2020 Reimagined

The Cambridge-based biopharma company wants to advance earlier diagnosis or slow the progression of chronic kidney disease.


Progress for AstraZeneca on cardiovascular, COPD and lung cancer drugs

Progress for AstraZeneca on cardiovascular, COPD and lung cancer drugs

Progress for AstraZeneca on cardiovascular, COPD and lung cancer drugs

One of them has the ‘potential to improve not only the quality and the length of life for millions’.

1

Could this £2.50 gargle test developed in Cambridge be the solution to Covid-19 testing challenge?

Could this £2.50 gargle test developed in Cambridge be the solution to Covid-19 testing challenge?

Could this £2.50 gargle test developed in Cambridge be the solution to Covid-19 testing challenge?

The v-SCREEN test invented by Prof Ray Iles, working with a University of Cambridge lab, could be a game-changer.

3

Research test kit for Covid-19 based on Avacta’s Affimer technology is released by Adeptrix

Research test kit for Covid-19 based on Avacta’s Affimer technology is released by Adeptrix

Research test kit for Covid-19 based on Avacta’s Affimer technology is released by Adeptrix

It is continuing to work with the UK government’s CONDOR programme for approval for diagnostic use.


Covid-19 virus neutralising antibodies discovered by IONTAS with FairJourney Biologics

Covid-19 virus neutralising antibodies discovered by IONTAS with FairJourney Biologics

Covid-19 virus neutralising antibodies discovered by IONTAS with FairJourney Biologics

It raises hopes of effective new therapies.


Illumina to acquire its spin-out GRAIL for $8bn in drive to accelerate cancer diagnosis by blood screening

Illumina to acquire its spin-out GRAIL for $8bn in drive to accelerate cancer diagnosis by blood screening

Illumina to acquire its spin-out GRAIL for $8bn in drive to accelerate cancer diagnosis by blood screening

The Granta Park-based genomic sequencing giant expects a commercial launch in 2021.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More